Literature DB >> 8642704

The membrane-binding domain of the Rous sarcoma virus Gag protein.

M F Verderame1, T D Nelle, J W Wills.   

Abstract

The Gag protein of Rous sarcoma virus (RSV) can direct particle assembly and budding at the plasma membrane independently of the other virus-encoded products. A previous deletion analysis has suggested that the first 86 amino acids of RSV Gag constitute a large membrane-binding domain that is absolutely required for these processes. To test this hypothesis, we inserted these residues in place of the N-terminal membrane-binding domain of the pp60v-src, a transforming protein whose biological activity requires plasma membrane localization. The ability of the Src chimera to induce cellular transformation suggests that the RSV sequence indeed contains an independent, functional domain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642704      PMCID: PMC190120     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Identification of retrovirus matrix proteins by lipid-protein cross-linking.

Authors:  R B Pepinsky; V M Vogt
Journal:  J Mol Biol       Date:  1979-07-15       Impact factor: 5.469

2.  Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.

Authors:  V M Vogt; R Eisenman; H Diggelmann
Journal:  J Mol Biol       Date:  1975-08-15       Impact factor: 5.469

3.  A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity.

Authors:  T D Nelle; J W Wills
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 4.  Subcellular localization of pp60src in RSV-transformed cells.

Authors:  J G Krueger; E A Garber; A R Goldberg
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

5.  Chemical crosslinking of proteins in avian sarcoma and leukemia viruses.

Authors:  R B Pepinsky; D Cappiello; C Wilkowski; V M Vogt
Journal:  Virology       Date:  1980-04-15       Impact factor: 3.616

6.  Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. An insight into virus assembly.

Authors:  A Gebhardt; J V Bosch; A Ziemiecki; R R Friis
Journal:  J Mol Biol       Date:  1984-04-05       Impact factor: 5.469

7.  Adhesion plaques of Rous sarcoma virus-transformed cells contain the src gene product.

Authors:  L R Rohrschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

8.  Fine-structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping.

Authors:  R B Pepinsky; V M Vogt
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses.

Authors:  L A Lipsich; A J Lewis; J S Brugge
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

10.  Localization of lipid-protein and protein-protein interactions within the murine retrovirus gag precursor by a novel peptide-mapping technique.

Authors:  R B Pepinsky
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

View more
  34 in total

1.  Insertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway.

Authors:  N K Krishna; J W Wills
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.

Authors:  Lisa Z Scheifele; Rachel A Garbitt; Jonathan D Rhoads; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.

Authors:  J B Bowzard; R J Visalli; C B Wilson; J S Loomis; E M Callahan; R J Courtney; J W Wills
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Link between genome packaging and rate of budding for Rous sarcoma virus.

Authors:  Eric M Callahan; John W Wills
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Evolution of feline immunodeficiency virus Gag proteins.

Authors:  Evan Burkala; Mary Poss
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

Review 7.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

8.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmission.

Authors:  I Le Blanc; A R Rosenberg; M C Dokhélar
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Conditions for copackaging rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding.

Authors:  R P Bennett; J W Wills
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.